Sabine de Wild

Research activity per year

Filter

De-escalation of radiotherapy after primary chemotherapy in cT1-2N1 breast cancer (RAPCHEM; BOOG 2010-03): 5-year follow-up results of a Dutch, prospective, registry study
de Wild, S. R., de Munck, L., Simons, J. M., Verloop, J., van Dalen, T., Elkhuizen, P. H. M., Houben, R. M. A., van Leeuwen, A. E., Linn, S. C., Pijnappel, R. M., Poortmans, P. M. P., Strobbe, L. J. A., Wesseling, J., Voogd, A. C. & Boersma, L. J., Sept 2022, In: Lancet oncology. 23, 9, p. 1201-1210 10 p.
Research output: Contribution to journal › Article › Academic › peer-review

Open Access
File

191 Downloads (Pure)
MINImal vs. MAXimal Invasive Axillary Staging and Treatment After Neoadjuvant Systemic Therapy in Node Positive Breast Cancer: Protocol of a Dutch Multicenter Registry Study (MINIMAX)
de Wild, S. R., Simons, J. M., Peeters, MJTFDV., Smidt, M. L., Koppert, L. B. & MINIMAX Group, 1 Jan 2022, In: Clinical Breast Cancer. 22, 1, p. E59-E64 6 p.
Research output: Contribution to journal › Article › Academic › peer-review

Open Access
Prognostic effect of nodal status before and after neoadjuvant chemotherapy in breast cancer: a Dutch population-based study
de Wild, S. R., Koppert, L. B., de Munck, L., Peeters, M-J. T. F. D. V., Siesling, S., Smidt, M. L. & Simons, J. M., Apr 2024, In: Breast Cancer Research and Treatment. 204, 2, p. 277-288 12 p.
Research output: Contribution to journal › Article › Academic › peer-review

Open Access

Research output